Pfizer Sues Sandoz Over Lipitor Generics In Japan
This article was originally published in PharmAsia News
Executive Summary
Pfizer Inc. has filed an infringement lawsuit with Tokyo District Court over Lipitor (atorvastatin) generics marketed by Sandoz.